SilkTech Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.56M

  • Investors
  • 8

SilkTech General Information

Description

Developer of silk-based anti-inflammatory therapies intended to treat inflammation-based chronic conditions. The company offers silk-based protein products by using technology that removes non-natural and potentially unhealthy additives in silk proteins and can be dissolved in water at high concentrations without affecting the taste, texture, color, or smell, enabling medical practitioners to get protein biotherapeutics for the treatment of conditions like dry eye disease.

Contact Information

Formerly Known As
Silk Tears
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3700 Annapolis Lane North
  • Suite 105
  • Plymouth, MN 55447
  • United States
+1 (763)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3700 Annapolis Lane North
  • Suite 105
  • Plymouth, MN 55447
  • United States
+1 (763)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SilkTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 18-Jul-2024 $3.56M Completed Generating Revenue
3. Later Stage VC (Series A) 18-Apr-2019 Completed Generating Revenue
2. Grant 01-Apr-2019 $3.14M Completed Generating Revenue
1. University Spin-Out 01-Jan-2013 Completed Startup
To view SilkTech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SilkTech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of silk-based anti-inflammatory therapies intended to treat inflammation-based chronic conditions. The company
Drug Discovery
Plymouth, MN
3 As of 2023

Boston, MA
 

Plymouth Meeting, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SilkTech Competitors (15)

One of SilkTech’s 15 competitors is Centrexion Therapeutics, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Centrexion Therapeutics Venture Capital-Backed Boston, MA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Domainex Venture Capital-Backed Saffron Walden, United Kingdom
Arbutus Biopharma Corporation Warminster, PA
Vir Biotechnology Formerly VC-backed San Francisco, CA
You’re viewing 5 of 15 competitors. Get the full list »

SilkTech Patents

SilkTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220017602-A1 Ocular compositions and methods Pending 15-Nov-2019
AU-2020419590-A1 Stable formulations of silk-derived protein Pending 15-Nov-2019
CA-3158243-A1 Stable formulations of silk-derived protein Pending 15-Nov-2019
EP-4057941-A2 Stable formulations of silk-derived protein Pending 15-Nov-2019
EP-4057941-A4 Stable formulations of silk-derived protein Pending 15-Nov-2019 A61P27/02
To view SilkTech’s complete patent history, request access »

SilkTech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SilkTech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Big Red Ventures Venture Capital Minority
Skyview Capital Ventures Corporate Venture Capital Minority
StartX (US) Accelerator/Incubator Minority
Trousdale Ventures Venture Capital Minority
United States Department of War Government
You’re viewing 5 of 8 investors. Get the full list »

SilkTech FAQs

  • When was SilkTech founded?

    SilkTech was founded in 2013.

  • Where is SilkTech headquartered?

    SilkTech is headquartered in Plymouth, MN.

  • What is the size of SilkTech?

    SilkTech has 3 total employees.

  • What industry is SilkTech in?

    SilkTech’s primary industry is Drug Discovery.

  • Is SilkTech a private or public company?

    SilkTech is a Private company.

  • What is SilkTech’s current revenue?

    The current revenue for SilkTech is .

  • How much funding has SilkTech raised over time?

    SilkTech has raised $14.8M.

  • Who are SilkTech’s investors?

    Big Red Ventures, Skyview Capital Ventures, StartX (US), Trousdale Ventures, and United States Department of War are 5 of 8 investors who have invested in SilkTech.

  • Who are SilkTech’s competitors?

    Centrexion Therapeutics, Inovio Pharmaceuticals, Domainex, Arbutus Biopharma, and Vir Biotechnology are some of the 15 competitors of SilkTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process